VERONICA WILBUR: Open Payments
NPI 1699755678 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 50 payments from 21 companies in 2025. Trend: 2023 $564 · 2024 $582 · 2025 $1,112
Food & beverage: $1,112
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 4 | $144 |
| Verona Pharma, Inc. | 8 | $140 |
| AstraZeneca Pharmaceuticals LP | 4 | $104 |
| Lilly USA, LLC | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| ABBVIE INC. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $50 |
| Viatris Specialty LLC | 2 | $45 |
Products named: WAKIX, Ohtuvayre, REXULTI, CAPLYTA, XIFAXAN, MOUNJARO, LUMRYZ, YUPELRI.
Industry payments across DE — which companies pay providers there.
